Agile_Logo-color on white.jpg
Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021
22. Oktober 2021 08:01 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2021 financial results after...
Agile_Logo-color on white.jpg
Agile Therapeutics Applauds Congressional Chairs’ Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act
12. Oktober 2021 08:01 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging...
Agile_Logo-color on white.jpg
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
08. Oktober 2021 16:05 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Josephine Torrente has been appointed to the Company’s...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
07. Oktober 2021 16:05 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
04. Oktober 2021 08:02 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that the California Medicaid Program, Medi-Cal, has placed...
Agile_Logo-color on white.jpg
Agile Therapeutics to Participate in Upcoming Investor Conferences
07. September 2021 07:30 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the...
Agile_Logo-color on white.jpg
Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women’s Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system
20. August 2021 07:30 ET | Agile Therapeutics, Inc.
Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports Second Quarter 2021 Financial Results
26. Juli 2021 16:05 ET | Agile Therapeutics, Inc.
Total Prescriptions (TRx) Grew 171% in Second Quarter Prescribers, New Prescriptions and Refill Rates Continue to Grow in Second Quarter Company Continues to Progress on Expanding Access...
Agile_Logo-color on white.jpg
Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference
12. Mai 2021 08:00 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports First Quarter 2021 Financial Results
04. Mai 2021 16:05 ET | Agile Therapeutics, Inc.
Prescription Growth Reflects Increasing Demand for Twirla Base of Prescribers Continues to Grow in First Quarter 2021 Growing Distribution Network and Marketing Efforts Expected to Drive Healthcare...